- Previous Close
5,256.55 - Open
5,260.00 - Bid --
- Ask --
- Day's Range
5,232.55 - 5,330.00 - 52 Week Range
4,636.55 - 5,850.00 - Volume
3,788 - Avg. Volume
8,992 - Market Cap (intraday)
88.042B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
37.21 - EPS (TTM)
142.45 - Earnings Date May 29, 2025
- Forward Dividend & Yield 160.00 (3.04%)
- Ex-Dividend Date Feb 21, 2025
- 1y Target Est
--
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.
www.pghealthindia.com1,336
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: PGHL.NS
View MorePerformance Overview: PGHL.NS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PGHL.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PGHL.NS
View MoreValuation Measures
Market Cap
87.30B
Enterprise Value
84.46B
Trailing P/E
36.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.67
Price/Book (mrq)
14.29
Enterprise Value/Revenue
7.42
Enterprise Value/EBITDA
24.51
Financial Highlights
Profitability and Income Statement
Profit Margin
20.40%
Return on Assets (ttm)
21.08%
Return on Equity (ttm)
33.41%
Revenue (ttm)
11.6B
Net Income Avi to Common (ttm)
2.37B
Diluted EPS (ttm)
142.45
Balance Sheet and Cash Flow
Total Cash (mrq)
2.73B
Total Debt/Equity (mrq)
1.36%
Levered Free Cash Flow (ttm)
2.16B